EphA2:?

Giorgia Giordano1,2, Cristina Tucciarello1,3, Alessandra Merlini2

  • 1Sarcoma Unit, Candiolo Cancer Institute, FPO-IRCCS, 10060, Candiolo, TO, Italy.

概括

铁氨酸激酶受体以林A型受体2 (EphA2) 在骨肉瘤中过度表达,导致瘤进展. 准EphA2为治疗这些侵袭性癌症提供了新的精准医学策略.